FDA chief backs 2 new path­ways to spur drug im­por­ta­tion — but an­a­lysts shrug it all off

HHS chief Alex Azar has rolled out a plan to spur the im­por­ta­tion of cheap­er over­seas drugs — in­clud­ing Cana­da — and he has re­cruit­ed act­ing FDA chief Ned Sharp­less as an ad­vo­cate who will help make it hap­pen.

Azar an­nounced Wednes­day that the Trump ad­min­is­tra­tion is post­ing a no­tice of pro­posed rule­mak­ing that will au­tho­rize states, drug whole­salers and man­u­fac­tur­ers to launch pi­lot im­por­ta­tion projects out of Cana­da with the help of HHS.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER